CALGARY, AB, Sept. 29, 2026 — NGIF Capital, a venture investor with a ten-year track record backing innovation in the natural gas sector, today announced it will operate as  (Northreach), reflecting a significantly expanded investment mandate. 

NGIF Capital is now Northreach Capital
Northreach is expanding beyond its natural gas mandate to back technology solutions to modernize energy-intensive heavy industries that power the global economy, extracting more value from existing and future assets and making them smarter, leaner, and more resilient. The firm’s mission is to invest in asset-light technology companies that increase asset value, lower operating costs, and solve system bottlenecks with solutions that transfer across heavy industry operators. Northreach pursues this mission with discipline, supporting portfolio companies operationally and partnering with industry to accelerate commercialization and adoption, with the underwriting rigour institutional capital expects from a top-tier venture manager.

“Ten years of working with operators and investing in solutions for the natural gas industry taught us that increasing the value of industrial assets, lowering operating costs, reducing emissions, and resolving system bottlenecks is what wins,” said John Adams, Founder, CEO, and General Partner of Northreach Capital. “Northreach broadens the mandate; we’re backing companies that do exactly that across multiple heavy-industry sectors, with the same discipline, the same team, and the same ecosystem that delivered our first decade of results.”

Northreach’s vision is a future where heavy industry, across its primary sectors (oil & natural gas, mining, minerals) and secondary sectors (LNG, steel, manufacturing, cement, petrochemicals, refining & fuels), competes on higher efficiency, fewer constraints, and stronger balance sheets that fuel long-term sector growth. The mandate also extends to AI data centres, given their similar profile of energy demand and asset lifespan.

NGIF Accelerator continues the NGIF brand
The NGIF brand continues in tandem: NGIF Accelerator continues funding innovation programs, backed by industry and government capital, to demonstrate and validate new technologies for adoption in the natural gas sector and transfer to other heavy industries. Together, NGIF Accelerator and Northreach Capital reinforce each other’s work, validating emerging technologies through operators while investing capital that builds market traction and drives adoption across industries.

The transition changes the firm’s name and mandate only: the team, portfolio, existing fund commitments, and office locations all continue without interruption. During the transition period, the firm will be identified as Northreach Capital, formerly NGIF Capital.

About Northreach Capital
Northreach Capital (formerly NGIF Capital) is a venture capital firm with a dedicated team of professionals offering equity financing for startups solving critical constraints across heavy industry’s primary and secondary sectors. Northreach is unique in how it brings industry leadership to every investment with strong connections to every part of the value chain, partnering with founders to achieve scalable, repeatable deployment and global scale. Learn more at northreachcapital.ca

Fund Information:
John Adams
Founder, CEO, and General Partner, Northreach Capital
(613)-748-0057
[email protected]

SOURCE Northreach Capital

Vast-10M is the first frontier AI model with ten million tokens of context

IRVINE, Calif., Sept. 29, 2026 — Today AI research laboratory Voltropy unveiled Vast-10M, the first frontier AI model with ten million tokens of context. The new model can process ten times as much data at once as the flagship models from Anthropic and OpenAI.

“For almost three years, frontier models have been stuck around a million tokens of context,” said Clint Ehrlich, Voltropy’s CEO and co-founder. “Vast-10M breaks the million token barrier while delivering true frontier intelligence. Users can paste in the entire U.S. tax code or earnings call transcripts for every company in the S&P 500.”

The technology behind Vast-10M is Voltropy Scalable Attention (VSA), a new algorithm which can be used to expand the context windows of existing transformers. VSA delivers ten million tokens of context in three model sizes:

• Vast-10M-Flash, based on DeepSeek V4 Flash;
• Vast-10M-Medium, based on GLM 5.2; and
• Vast-10M-Pro, based on DeepSeek V4 Pro.

“Prior techniques for extending model context degraded intelligence,” said Ted Blackman, Voltropy’s CTO and co-founder. “VSA does the opposite. It actually makes models smarter at shorter context lengths. That boost lets Vast-10M compete with the best models in the world, even on tasks that fit inside those models’ context windows.”

On the industry-standard BEAM benchmark, Vast-10M-Flash beats Anthropic’s flagship model, Fable 5.1, at the one-million-token tier. It achieves parity with OpenAI’s GPT-6 Astra. Vast-10M’s context window is 10x larger than Fable’s and 9.5x larger than Astra’s.

The entirety of Vast-10M’s immense context window is fully functional. On BEAM, Vast-10M-Flash has greater recall ability at ten million tokens than its base DeepSeek model has at one million tokens.

Users can sign up for early access to Vast-10M starting today at www.voltropy.com.

About Voltropy

Voltropy PBC is an AI research laboratory based in Orange County, California, whose mission is to build artificial superintelligence aligned with the long-term flourishing of civilization.

The company is known for LCM: Lossless Context Management, an agentic architecture that was integrated with OpenClaw and Hermes Agent after outperforming Anthropic’s Claude Code on the OOLONG benchmark. 

Vast-10M is Voltropy’s first model family. A full technical report is available at www.voltropy.com.  

Media Contact
Clint Ehrlich
CEO, Voltropy
(818) 473-5404
[email protected] 

SOURCE Voltropy

Founded by former Tesla supply chain leaders, Atomic already automates 90% of purchasing for DoorDash’s DashMart business and helped Good Chop cut inventory in half while more than doubling revenue.

BOSTON, Sept. 29, 2026 — Atomic, the AI-native supply chain planning platform, today announced a $12.5 million Series A led by Klass Capital and Madrona. Adrian Schauer of Klass Capital and Matt McIlwain of Madrona join Atomic’s board. 

Atomic will use the funding to extend its platform from planning and decision support into a control system that connects a company’s business objectives to its daily operating decisions, with AI agents extending the capability of human teammates. When demand shifts or supply tightens, planning teams have to understand what changed, compare responses and adjust what gets bought, built or moved. Atomic connects that work in one operating model. Teams can improve the logic behind a decision and carry that improvement into the orders the business places every day.

The company was founded by Michael Rossiter, Neal Suidan, and Jeff Goodrich, who together led Sales and Operations Planning and planning at Tesla through the Model 3 ramp-up and built a 50-person planning engineering organization. The company was incubated at DVx Ventures, the venture firm founded by former Tesla President Jon McNeill, who worked alongside the team at Tesla and now serves on Atomic’s board.

“Most companies can’t justify building the kind of planning engineering team we had at Tesla,” said Rossiter, Atomic’s co-founder and CEO. “They’re still running critical parts of their business through legacy software, hundreds of spreadsheets and individual heroics. Atomic gives them that capability as a product.”

Companies can deploy Atomic’s sales and operations planning layer in about 30 days using the data they already have. From there, Atomic can expand into detailed planning and execution, running alongside a company’s existing ERP rather than requiring the business to rebuild its processes around new software.

For DoorDash’s DashMart business – the company’s convenience and essentials store – Atomic now automates 90% of purchasing across hundreds of sites. DashMart migrated to Atomic in about three months with feature parity and zero business disruption. Its team recently used Atomic’s AI to build new purchasing logic for how primary and backup suppliers should be used in roughly an hour. Atomic then applied that logic across daily purchases, helping shift more volume toward primary suppliers and improve gross margins.

“Atomic has helped us plan and manage inventory more proactively, so we can maintain high service levels for consumers even in times of disruption,” said Nick Palefsky, Director of New Business Verticals at DoorDash. “Turning a forecast into the right purchase at the right site takes operating judgment we’ve built over years. What to carry where, how to substitute when a supplier misses. Atomic is how we apply that judgment across our network every day.”

Additionally, Good Chop, HelloFresh’s meat box subscription business, used Atomic to reduce inventory on hand from eight or nine weeks to four while more than doubling revenue and expanding its distribution network and product range.

“Atomic helped us keep inventory under control as we expanded the business. It’s the core engine we use to plan supply and place purchase orders,” said Seb Tron, president of Good Chop.

Atomic’s AI agent platform, Nucleus, is also in daily use by customers for tasks including S&OP preparation, inventory questions and supply-risk checks. The new funding will be used to expand the platform and support larger enterprise deployments.

Adrian Schauer of Klass Capital and Matt McIlwain of Madrona will join Atomic’s board alongside Jon McNeill, co-founder and CEO of DVx Ventures and the former President of Tesla. DVx incubated Atomic and has backed the company since its earliest days.

“We’ve never heard customers talk about a software vendor the way they talk about Atomic. They trust it with daily operating decisions and are asking for more,” said Daniel Klass, founder and managing partner of Klass Capital.

“We backed Atomic at the seed because the founders had lived this problem at Tesla. A year and a half later, their platform runs daily purchasing across DoorDash’s DashMart network. Most enterprise AI stops at a recommendation. Atomic acts on the plan and shows its work. We’re pleased to co-lead this round and join the board,” said Matt McIlwain, managing director of Madrona.

“Michael, Neal and Jeff helped build the system that allowed Tesla to operate at a scale and speed that traditional supply chain software simply wasn’t designed for,” said McNeill. “What gets us excited about Atomic was the opportunity to take what they learned solving one of the hardest supply chain problems in the world and turn it into something any company can use. AI now makes it possible to give companies not just better forecasts, but a system that can actually make and execute decisions.”

Atomic’s customers include DoorDash’s DashMart, GoodChop (HelloFresh), Starface World, OOFOS, LMNT and Vincero.

To learn more, visit atomic.supply.

About Atomic
Atomic is building the AI control system for physical goods companies. Founded by former Tesla planning leaders, Atomic gives planning teams a model of their business at the product level, recommendations that show their reasoning, and AI agents that take on more of the work as trust builds. Atomic is backed by DVx Ventures, Klass Capital, Madrona, Alumni Ventures, and Sandberg Bernthal Venture Partners. Learn more at atomic.supply.

Media contact: 
Lindsay Mahaney 
[email protected]

SOURCE Atomic

New $2M research investment aims to solve a major unmet need in pulmonary medicine: accurately assessing indeterminate lung nodules and accelerating life-saving diagnoses

WASHINGTON, Sept. 29, 2026 — LUNGevity Foundation, the nation’s leading lung cancer–focused nonprofit organization, today announced its support of two innovative and ambitious research projects designed to fundamentally change how clinicians evaluate indeterminate pulmonary nodules (IPNs), small spots on chest CT scans that may be an early sign of lung cancer.

Each year, more than 1.5 million Americans receive CT scan results showing an IPN. Yet existing non-invasive diagnostic approaches often fall short, leaving patients and providers unable to determine whether a nodule is benign or malignant. As a result, many individuals undergo unnecessary invasive procedures, experience prolonged diagnostic delays, or live with profound uncertainty and anxiety during this critical window of early detection.

Through targeted investment and strategic collaboration, LUNGevity is working with Rising Tide Foundation for Clinical Cancer Research (RTFCCR) to close this diagnostic gap and accelerate the development of more precise, non-invasive tools that can identify cancer earlier, reduce harm, and improve outcomes for patients worldwide.

While both of these studies represent bold, patient-centered innovation needed to transform how we detect lung cancer, each offers a unique approach for how health care teams assess a person’s risk for the disease.

“We know the most effective health care tools must work for both the patient and the clinic. By advancing two strong choices in assessing lung cancer risk, we are opening the door for more people to have access to this information. One project aims to combine radiomics and liquid biopsy to determine a person’s lung cancer risk, while the other project builds on advanced AI algorithms to offer a personalized risk assessment,” said Upal Basu Roy, PhD, MPH, executive director of LUNGevity Research. “We are proud to partner with Rising Tide Foundation to support the development of tools that can finally bring clarity to millions of patients facing uncertainty after a CT scan.” 

The two projects are supported through the 2026 RTFCCR/LUNGevity Early Detection Award, a partnership dedicated to accelerating high-impact early detection research that can be rapidly translated into clinical practice.

Award Recipients

Project: Validation of an Integrated Radiomic and Cell-Free DNA Methylome Biomarker for Risk Stratification of Indeterminate Pulmonary Nodules
Awardee: Steven Dubinett, MD
Institution: University of California, Los Angeles
Amount: $1 million (over 3 years)

This three-year study aims to develop a powerful diagnostic tool that integrates advanced CT imaging analysis with a blood-based test to predict the likelihood that an indeterminate pulmonary nodule is cancerous. The research team will validate the approach in a cohort of 500 patients across UCLA and Veterans Affairs hospitals, with the ultimate goal of providing clinicians with a reliable, non-invasive method to assess cancer risk in patients with IPNs.

Project: The RESOLVE Study – Risk Estimation Using Sybil for Lung Nodules
Awardee: Lecia Sequist, MD, MPH
Institution: Massachusetts General Hospital / Harvard Medical School
Amount: $1 million (over 3 years)

This three-year clinical trial will evaluate Sybil, an open-source artificial intelligence model capable of estimating lung cancer risk directly from CT scans, without reliance on human annotation of the images. The study will enroll 340 adults ages 35–75 with low-risk pulmonary nodules, testing the real-world performance of AI-driven risk assessment in a diverse clinical population.

If successful, these studies could:

• Significantly reduce unnecessary biopsies and surgeries
• Expand access to early detection through non-invasive approaches, particularly for women without common risk factors for lung cancer, who now represent a growing proportion of lung cancer diagnoses
• Enable faster identification of high-risk patients who require prompt follow-up or early intervention

“Each of these projects is led by a globally recognized expert in lung cancer research and developed with contribution of expert patient partners. They reflect the kind of visionary science that can redefine patient care,” said Zoraide Granchi, PhD, senior scientific program manager of the Rising Tide Foundation for Clinical Cancer Research. “We are proud to once again partner with LUNGevity to accelerate patient-focused solutions that bring hope, clarity, and progress to patients and families around the world.”

LUNGevity Foundation is grateful to Upstage Lung Cancer for their continued partnership in supporting early detection research.

About Rising Tide for Clinical Cancer Research

Founded in 2010 and headquartered in Schaffhausen, Switzerland, the Rising Tide Foundation for Clinical Cancer Research (RTFCCR) is a charitable, non‑profit organization dedicated to advancing patient‑centered clinical cancer research. Its mission is to support innovative clinical trials that lead to less toxic therapies, earlier detection, and improved quality of life for cancer patients, with a strong focus on projects that address real patient needs and deliver meaningful impact on survival and well‑being. 

Learn more at: https://www.risingtide-foundation.org 

About LUNGevity Foundation

LUNGevity, the nation’s leading lung cancer organization, is transforming what it means to be diagnosed and live with lung cancer. LUNGevity seeks to make an immediate impact on quality of life and survivorship for everyone touched by the disease, while promoting health equity by addressing disparities throughout the care continuum.

• Through research, we use an innovative and holistic approach to finding lung cancer earlier when it is most treatable; advance research into new treatments so people may live longer and better; and ensure a diverse, vital pipeline of investigators for the future of the lung cancer field.
• Through advocacy, we foster groundbreaking collaborations to ensure all people have access to screening, biomarker testing, and treatment breakthroughs.
• Through community, we educate, support, and connect people affected by lung cancer so that they can get the best healthcare and live longer and better lives.

Comprehensive resources include a medically vetted and patient-centric website, Patient Gateways for specific types of lung cancer, a toll-free HELPLine for personalized support, international survivor conferences, and tools to find a clinical trial. All these programs are designed to help us achieve our vision: a world where no one dies of lung cancer. LUNGevity Foundation is proud to be a four-star Charity Navigator organization.

Please visit www.LUNGevity.org to learn more.

SOURCE LUNGevity Foundation

Explosive Growth and Rapid Industry Adoption Drive New Funding Round Just Months After Series A

SAN FRANCISCO, Sept. 25, 2026 — Outmarket AI, the leading AI platform purpose-built for insurance, today announced it has raised $34.5 million in Series B funding. The round was led by SignalFire, with participation from Fika Ventures, Permanent Capital Ventures, TTV Capital and Dash Fund. Coming just a few months after the company announced a $17 million Series A, the latest investment brings Outmarket’s total funding to $56.5 million.

The decision to raise a Series B so soon after the previous round was driven by Outmarket’s explosive growth and rapid market adoption this year. The platform has scaled at a record pace, recently surpassing 10,000 active users. Today, over 300 agency customers, including over 25% of the Top 100 insurance agencies, rely on Outmarket daily to transform fragmented agency data into intelligent workflows. To support this scale, Outmarket has significantly expanded its growing team with top-tier talent spanning engineering, insurance operations, and customer success.

“We didn’t set out to raise again this soon, but the industry told us what it wants,” said Vishal Sankhla, CEO and Co-founder of Outmarket AI. “Agencies don’t want another point solution. They want an intelligence layer that understands their data and does the work. Every workflow we automate frees up hours that go back to clients, and that’s the future we’re building toward: an industry where the people who protect businesses and families spend their time on judgment and relationships, not on rekeying data.  With this investment, we’re accelerating our roadmap to bring even more value to the agencies that depend on us every day.”

Outmarket’s comprehensive platform connects directly to agency management systems (AMS) automating complex, high-stakes processes across commercial, benefits, personal lines, and specialty insurance. Customers using Outmarket consistently report drastic reductions in manual work, minimized E&O exposure through AI-assisted policy gap detection, and increased revenue. For employee benefits professionals specifically, Outmarket’s tailored capabilities have become indispensable for streamlining renewals, benchmarking, and proposal generation. The company will also begin extending its capabilities to carriers later this year, laying the groundwork for a more connected market where information moves between agencies and carriers without manual handoffs.

“The scale we’ve reached this year has allowed us to build increasingly powerful capabilities into the platform,” said Anshu Jain, CTO and Co-founder of Outmarket AI. “Our architecture unifies structured and unstructured data so insurance professionals can execute workflows grounded in their actual policies, contracts and client records. When you build an AI platform that natively speaks the language of insurance, the value is immediate and it compounds with every workflow we add.”

New Certificates of Insurance Workflow

In conjunction with the Series B announcement, Outmarket released a new Certificates workflow. Certificates of insurance are one of the highest volume and most thankless tasks in every agency. Account managers issue thousands of certificates a year, often within hours of a client request, and every one carries E&O exposure if a holder, endorsement or coverage requirement is missed. Outmarket’s Certificates workflow automates the entire process. It reads the client’s contract or lease, extracts the insurance requirements, checks them against the policies already in the AMS, flags any gaps, and generates the completed ACORD certificate with the correct holders, additional insureds and endorsements attached. Early customers report issuing certificates in a few minutes and significantly reducing certificate-related errors.

The release builds on Outmarket’s rapid product momentum, including a recently-launched AI-powered loss run extraction and analysis tool, comprehensive employee benefits capabilities designed to eliminate manual workflows, and a unified data intelligence platform that provides agencies with a single source of truth.

“We’ve tracked Outmarket’s trajectory closely, and their execution over the past year has been nothing short of exceptional,” said Tony Pezzullo, Partner at SignalFire. “To capture this much market share in such a short window is a rare achievement, and even rarer in a complex vertical like insurance. Outmarket isn’t just riding the AI wave; they are the undisputed market leaders setting the standard for how agencies will operate in the intelligence era. We are thrilled to lead this Series B and double down on their vision.”

To learn more about Outmarket AI, visit: https://outmarket.ai/

About Outmarket AI
Outmarket is the leading AI platform for insurance. Purpose-built for agencies, Outmarket delivers intelligent workflows across commercial, benefits, personal lines, and specialty insurance that turn hours of manual work into minutes. Over 300 of the world’s top agencies trust Outmarket to reduce E&O exposure, accelerate client delivery, and unlock new revenue.

Outmarket is headquartered in San Francisco, California. Learn more at https://outmarket.ai/.

Kevin LaHaise
Outmarket AI 
[email protected]

SOURCE Outmarket AI Inc

Leaders from Parabilis Medicines, HawkEye 360 and Cerebras joined investors and leading clinicians at the firm’s 2026 Celebration in Toronto

TORONTO, Sept. 28, 2026 — Sixty Degree Capital (“SDC”), a global, multi-stage venture capital firm investing across technology and healthcare, continued its strong portfolio momentum in 2026. Building on the firm’s history of successful exits, five SDC portfolio companies have completed initial public offerings in 2026, including two record-setting offerings.

SpaceX, Parabilis Medicines, Cerebras, HawkEye 360 and Lime each began trading on U.S. exchanges between May and July. SpaceX’s offering of approximately US$75 billion is the largest IPO in history, and Parabilis Medicines’ US$770 million offering is the largest biotech IPO in history. GrubMarket has also filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission.

“A public listing happens in a single day, but it rests on years of work that most people never see,” said Robert Guo, President of Sixty Degree Capital. “This year’s listings add to a record our founders have been building since the firm’s earliest days. Each of these companies took on hard problems at the frontier of science and technology and executed with real discipline. We are proud to continue as their partner, and we remain focused on backing the companies that will define the decade ahead.”

SDC marked this year’s milestones at its 2026 Celebration, held on August 11 at the Donalda Club in Toronto. The evening convened founders, investors, scientists, clinicians and partners from across the firm’s network, with a program that followed the path from scientific discovery to global scale.

Dr. Mathai Mammen, Chief Executive Officer of Parabilis Medicines, joined SDC Managing Director Dr. Cheryl Kuai in conversation on building biotechnology companies and translating breakthrough science into new medicines. John Serafini, Chief Executive Officer of HawkEye 360, and Nish Sinnadurai, Senior Vice President of Engineering and Canada Country Manager at Cerebras, spoke to the rise of space-based intelligence and the compute infrastructure behind the next generation of artificial intelligence, respectively.

The program closed with a panel on longevity and healthspan, moderated by Dr. Kenneth Grisé, Principal at SDC. Dr. Douglas Vaughan, Founding Director of the Potocsnak Longevity Institute and Chief Academic Officer of Northwestern Medicine, drew on decades of research into the biology of aging. Dr. Hubert Walinski, Chief Scientific Officer, Life Sciences at Portland Holdings, offered a pharmaceutical industry view, and James Mayer, Chief Operating Officer of CABHI and Partner at CABHI Ventures, spoke to innovation in aging and brain health.

This year’s listings are the latest outcome of an approach that has guided SDC since its founding in 2018. Its investment approach rests on people, timing and sector expertise, applied by specialized teams of former founders, operators, PhDs, research scientists and investment professionals. That depth allows SDC to recognize potential early, evaluate complex opportunities with conviction and remain a steady partner as companies grow. As innovation across technology and healthcare accelerates, SDC continues to focus on partnering with the founders building what comes next.

About Sixty Degree Capital

Sixty Degree Capital is a global multi-stage venture capital firm based in Toronto. The firm invests in category-defining companies across technology and healthcare, primarily in the United States, with select investments globally. In technology, SDC invests across artificial intelligence, space, defence, cybersecurity and digital infrastructure. In healthcare, SDC invests in pioneering biotechnology and healthcare technology companies that address significant unmet medical needs and have the potential to transform patient care. These investments are underpinned by deep scientific, technical and investment expertise across oncology, immunology, cardiovascular disease, central nervous system disorders and healthcare technology. Its multidisciplinary team partners with exceptional founders from early growth through the public markets.

This press release is for informational purposes only and does not constitute an offer to sell, or a solicitation of an offer to buy, any securities or interests in any fund managed by Sixty Degree Capital.

SOURCE Sixty Degree Capital

The Firm’s 70th acquisition carries a 6.4% going-in cap rate, the highest across all Elevest Capital funds to date.

SCOTTSDALE, Ariz., Sept. 28, 2026 — Elevest Capital, a Scottsdale-based private equity firm focused on passive multifamily real estate investing, today announced the launch of Fund 70, a 229 unit, 35 story high-rise apartment community in an A+ location in Downtown Dallas, Texas.

Built in 2007, the property has maintained 90%+ physical occupancy for the past 10 years and is currently 93% occupied, with no rental concessions offered over the past 12 months.

“Fund 70 is exactly the kind of asset we look for: a well-located, well-occupied property with a track record of stability,” said Adam Williams, Founder and CEO of Elevest Capital. “Buying at a 6.4% cap rate in an A+ downtown location is rare, and it’s the highest going-in cap rate we’ve ever purchased across all of our funds. For our investors, that means a strong starting point for both cash flow and long-term appreciation.”

Offering Highlights

The property is being acquired for $42 million, with approximately $19.1 million in total equity. Targeted terms include an 8.0% preferred return, 85/15 LP/GP split, 15.6% projected IRR, 2.01x projected equity multiple, and 4.0% targeted average cash flow.

The anticipated hold period is two to five years, with a projected 5.25% exit cap rate and a $200,000 minimum investment. Monthly cash flow distributions are anticipated to begin 60 to 90 days after closing.

About Elevest Capital

Elevest Capital is a private equity firm helping busy professionals and accredited investors build wealth through passive ownership of institutional-quality multifamily real estate. Guided by its tagline, “Real Estate Investing… Simplified,” the firm focuses on disciplined capital allocation and long-term investor relationships. Elevest Capital completed nine multifamily acquisitions in 2025, and Fund 70 represents its sixth offering of 2026.

Learn more at elevestcapital.com.

Media Contact

Elevest Capital
(480) 534-7066
[email protected] 
15125 N. Scottsdale Rd., Ste. 201, Scottsdale, AZ 85254

For informational purposes only. Not an offer to sell or solicitation to buy securities. Offers are made only through official offering documents detailing investment risks, fees, and objectives. All returns are targeted, projected, or anticipated and are not guaranteed. Investing involves risk, including potential loss of principal. Past performance does not predict future results. Investors should consult their financial, tax, and legal advisors before investing.

SOURCE Elevest Capital

Brick & Lace artist, songwriter and entrepreneur transforms a personal fashion challenge into a shapewear line designed for today’s boldest styles

MIAMI, Sept. 28, 2026 — For women who love cut-out dresses, asymmetrical silhouettes, one-shoulder styles, sheer panels and other fashion-forward looks, finding the right shapewear can sometimes create a problem of its own. For Nailah Thorbourne, the multi-platinum recording artist, songwriter and entrepreneur known professionally as Nyla and as one-half of the internationally recognized music duo Brick & Lace, that challenge became the inspiration for a new fashion venture.

That solution is Vlair Shapewear, an online fashion brand created to provide women with shapewear designed to complement, rather than interfere with, today’s bold clothing styles.

“I created Vlair because I saw a problem that needed to be solved, not just for myself, but for women who want to wear the clothes they love without having their shapewear work against the design,” said Nailah Thorbourne, Founder/CEO of Vlair Shapewear. “I wanted to create something that allows a woman to put on that dress, step out and feel confident in what she’s wearing.”

MADE FOR THE CUT-OUTS

Traditional shapewear is often designed with conventional clothing silhouettes in mind. But today’s fashion continues to embrace cut-outs, asymmetrical designs, one-shoulder styles, sheer panels and other looks that require a different approach to what is worn underneath.

Vlair was created with that reality in mind.

The brand’s current collection includes shaper panties, shaper skirts, shaping bodysuits, shaper shorts and loungewear, with designs intended to work with a range of contemporary looks. The brand’s signature positioning—”Made For the Cut Outs”—speaks directly to the fashion problem Vlair was created to address.

Among the collection is the Vlair Eclipse Bodysuit, which the company describes as being designed to disappear beneath one-shoulder dresses and sheer panels while helping provide shaping and support.

FROM THE STAGE TO THE FASHION INDUSTRY

Thorbourne brings a remarkable entertainment career to her role as a fashion entrepreneur. As a member of Brick & Lace, alongside her sister Nyanda Thorbourne, she helped establish an international recording career before continuing her work as a solo artist under the name Nyla.

Her career includes a significant collaboration with global electronic music group Major Lazer on the international hit “Light It Up.” The song and its remix achieved platinum certifications in multiple international markets, with the remix featuring Nyla and Fuse ODG ultimately earning 2× Platinum certification in the United States.

In 2026, Thorbourne returned to the global stage when Nyla performed “Light It Up” with Major Lazer during the closing ceremony of the Milano Cortina 2026 Olympic Winter Games in Verona, Italy. The official ceremony program lists the performance as part of the closing celebration.

That combination of music, international performance and fashion experience has given Thorbourne a firsthand understanding of style, image and the importance of confidence when stepping in front of an audience.

With Vlair, Thorbourne is taking that experience in a new direction—creating a fashion brand built around a problem she believes modern women shouldn’t have to accept.

“For me, Vlair is about more than shapewear. It’s about giving women the freedom to wear the look they want to wear and feel good doing it,” Thorbourne said. “The woman I designed Vlair for is bold, modern, and not afraid to step outside the box. She puts on the dress, walks through the door and owns the room.”

DESIGNED FOR THE VLAIR WOMAN

Vlair describes its customer as “The Vlair Woman”—a woman who wears what she wants, how she wants, and approaches her style with intention.

The company’s mission is to redefine shapewear for the modern woman through designs intended to promote confidence, individuality and the ability to wear today’s boldest fashions.

Rather than asking women to change their fashion choices to accommodate traditional shapewear, Vlair takes the opposite approach: design shapewear to accommodate the fashion.

DISCOVER VLAIR SHAPEWEAR

Vlair Shapewear is available exclusively online, allowing customers to explore the collection and find pieces designed for their individual style.

To discover the collection and learn more about Vlair Shapewear, visit:

www.vlair.store 

ABOUT VLAIR SHAPEWEAR

Vlair Shapewear is a fashion-forward shapewear brand founded by multi-platinum recording artist, songwriter and entrepreneur Nailah Thorbourne, known professionally as Nyla and as one-half of Brick & Lace. Created from a personal need to solve the challenges of wearing shapewear beneath today’s bold fashion silhouettes, Vlair is designed for the modern woman who wants to express her individuality without compromising confidence or style. With its “Made For the Cut Outs” philosophy, Vlair creates shapewear intended to work with contemporary fashion, including cut-outs, asymmetrical designs, one-shoulder styles and sheer looks.

Media Contact:

Leon Cosby

[email protected] 

404-448-9152

SOURCE Vlair Shapewear

New financing will fund the first customer deployments of standardized plasma diagnostic systems, giving fusion developers faster access to higher-quality, third-party-validated data.

TORONTO, Sept. 28, 2026 — Daedal Systems, which develops standardized plasma measurement systems for the nuclear fusion industry, today announced it has raised US$4.035 million to industrialize its measurement platform and deploy its first diagnostic systems with pilot customers. OMERS Ventures led the round, with participation from Garage Capital, Panache Ventures, Ripple Ventures, MaRS Investment Accelerator Fund (IAF), and a group of angel investors.

Fusion developers need detailed plasma measurements to understand how their reactor designs perform. Companies typically build diagnostic systems in-house, even though measurement is not core reactor intellectual property. This duplicates work across the industry and diverts time, capital, and talent from the technologies that differentiate their reactors.

“After building and deploying plasma measurement systems at General Fusion, I saw the same challenge across the sector: every company needs high-quality diagnostics, but too much time and capital go into recreating similar systems in-house,” said Henry Gould, founder and CEO of Daedal Systems. “Daedal was created to solve that problem by giving fusion companies access to standardized, high-quality plasma measurement systems that can improve the quality of their data and help them move faster toward commercialization.”

Daedal will use the financing to build its first three diagnostic systems and deploy prototypes under contract with pilot customers. The company has a research partnership with the University of Wisconsin-Madison.

Delivered as a service, Daedal’s platform can adapt to different fusion machines and reactor approaches. By producing higher-quality data faster and independently validating technical milestones for investors and partners, Daedal allows fusion companies to focus on reactor development while reducing their reliance on lengthy peer-review timelines.

“Advanced plasma diagnostics were among the key enabling technologies that led to ignition and target gain at the NIF” said Dr. Johan Frenje, a Technical Advisor to Daedal Systems, referring to National Ignition Facility’s historic fusion-ignition demonstration in 2022. “As fusion technology advances in the private sector, measurement solutions designed specifically for private-sector needs will be essential.”

“While fusion remains nascent, realizing its significant long-term potential will require a broader ecosystem of specialized companies and world-class expertise,” said Brian Kobus, managing partner at OMERS Ventures. “By building the measurement infrastructure the industry needs, Daedal can strengthen that ecosystem and attract the expertise required to advance this important technology.”

Initially, Daedal will serve the fusion industry, with a longer-term ambition to become a major instrumentation provider for commercial fusion power and other industries that require advanced measurement systems.

For more information, visit https://daedalsystems.com/.

About Daedal Systems
Daedal Systems builds standardized plasma measurement systems for the global fusion industry, enabling high-quality, fast-turnaround measurements and an accelerated path to fusion commercialization. Founded by Henry Gould, Daedal is based in Toronto.

About OMERS
OMERS is a jointly sponsored, defined benefit pension plan, with more than 1,000 participating employers ranging from large cities to local agencies, and 665,000 active, deferred and retired members. Our members include union and non-union employees of municipalities, school boards, local boards, transit systems, electrical utilities, emergency services and children’s aid societies across Ontario. OMERS teams work in Toronto, London, New York, Amsterdam, Luxembourg, Singapore, Sydney and other major cities across North America and Europe – serving members and employers, and originating and managing a diversified portfolio of high-quality investments in government bonds, public and private credit, public and private equities, infrastructure and real estate.

Media contact:
Remy Pinson
(510) 556-8517
[email protected]

SOURCE Daedal Systems